Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.

Chen Y, Ratnam K, Sundquist SM, Lujan B, Ayyagari R, Gudiseva VH, Roorda A, Duncan JL.

Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3281-92. doi: 10.1167/iovs.10-6538.

2.

Cone structure in retinal degeneration associated with mutations in the peripherin/RDS gene.

Duncan JL, Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Day S, Zhang Y, Roorda A.

Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1557-66. doi: 10.1167/iovs.10-6549.

3.
4.

Early-onset stargardt disease: phenotypic and genotypic characteristics.

Lambertus S, van Huet RA, Bax NM, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng CB.

Ophthalmology. 2015 Feb;122(2):335-44. doi: 10.1016/j.ophtha.2014.08.032. Epub 2014 Oct 17.

PMID:
25444351
5.

Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene.

Duncan JL, Ratnam K, Birch DG, Sundquist SM, Lucero AS, Zhang Y, Meltzer M, Smaoui N, Roorda A.

Invest Ophthalmol Vis Sci. 2011 Dec 20;52(13):9614-23. doi: 10.1167/iovs.11-8600.

6.

Cone structure in patients with usher syndrome type III and mutations in the Clarin 1 gene.

Ratnam K, Västinsalo H, Roorda A, Sankila EM, Duncan JL.

JAMA Ophthalmol. 2013 Jan;131(1):67-74. doi: 10.1001/2013.jamaophthalmol.2.

7.

Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology.

Charbel Issa P, Barnard AR, Singh MS, Carter E, Jiang Z, Radu RA, Schraermeyer U, MacLaren RE.

Invest Ophthalmol Vis Sci. 2013 Aug 19;54(8):5602-12. doi: 10.1167/iovs.13-11688.

8.

Outer retinal structure in patients with acute zonal occult outer retinopathy.

Mkrtchyan M, Lujan BJ, Merino D, Thirkill CE, Roorda A, Duncan JL.

Am J Ophthalmol. 2012 Apr;153(4):757-68, 768.e1. doi: 10.1016/j.ajo.2011.09.007. Epub 2011 Nov 20.

9.

Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.

Testa F, Rossi S, Sodi A, Passerini I, Di Iorio V, Della Corte M, Banfi S, Surace EM, Menchini U, Auricchio A, Simonelli F.

Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4409-15. doi: 10.1167/iovs.11-8201.

10.

Clinical and molecular characteristics of childhood-onset Stargardt disease.

Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K, Robson AG, Holder GE, Allikmets R, Michaelides M, Moore AT.

Ophthalmology. 2015 Feb;122(2):326-34. doi: 10.1016/j.ophtha.2014.08.012. Epub 2014 Oct 12.

11.

Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.

Ritter M, Zotter S, Schmidt WM, Bittner RE, Deak GG, Pircher M, Sacu S, Hitzenberger CK, Schmidt-Erfurth UM; Macula Study Group Vienna..

Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6416-25. doi: 10.1167/iovs.12-11550.

PMID:
23882696
12.

Foveal sparing in Stargardt disease.

van Huet RA, Bax NM, Westeneng-Van Haaften SC, Muhamad M, Zonneveld-Vrieling MN, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng CB.

Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7467-78. doi: 10.1167/iovs.13-13825.

PMID:
25324290
13.

A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

Fujinami K, Lois N, Mukherjee R, McBain VA, Tsunoda K, Tsubota K, Stone EM, Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M.

Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90. doi: 10.1167/iovs.13-12104.

PMID:
24265018
14.

Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).

Burke TR, Rhee DW, Smith RT, Tsang SH, Allikmets R, Chang S, Lazow MA, Hood DC, Greenstein VC.

Invest Ophthalmol Vis Sci. 2011 Oct 10;52(11):8006-15. doi: 10.1167/iovs.11-7693.

15.

High-resolution images of retinal structure in patients with choroideremia.

Syed R, Sundquist SM, Ratnam K, Zayit-Soudry S, Zhang Y, Crawford JB, MacDonald IM, Godara P, Rha J, Carroll J, Roorda A, Stepien KE, Duncan JL.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):950-61. doi: 10.1167/iovs.12-10707.

16.

High-resolution imaging with adaptive optics in patients with inherited retinal degeneration.

Duncan JL, Zhang Y, Gandhi J, Nakanishi C, Othman M, Branham KE, Swaroop A, Roorda A.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3283-91.

PMID:
17591900
17.

Cone abnormalities in fundus albipunctatus associated with RDH5 mutations assessed using adaptive optics scanning laser ophthalmoscopy.

Makiyama Y, Ooto S, Hangai M, Ogino K, Gotoh N, Oishi A, Yoshimura N.

Am J Ophthalmol. 2014 Mar;157(3):558-70.e1-4. doi: 10.1016/j.ajo.2013.10.021. Epub 2013 Nov 16.

PMID:
24246574
18.

High-resolution adaptive optics retinal imaging of cellular structure in choroideremia.

Morgan JI, Han G, Klinman E, Maguire WM, Chung DC, Maguire AM, Bennett J.

Invest Ophthalmol Vis Sci. 2014 Sep 4;55(10):6381-97. doi: 10.1167/iovs.13-13454.

19.

Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration.

Zayit-Soudry S, Duncan JL, Syed R, Menghini M, Roorda AJ.

Invest Ophthalmol Vis Sci. 2013 Nov 15;54(12):7498-509. doi: 10.1167/iovs.13-12433.

20.

Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus.

Oh KT, Weleber RG, Stone EM, Oh DM, Rosenow J, Billingslea AM.

Retina. 2004 Dec;24(6):920-8.

PMID:
15579991

Supplemental Content

Support Center